Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Lancet (London, England)
|
September 30, 1989
Use of apomorphine to test for dopamine responsiveness in Wilson's disease
J P Frankel, A Hughes, A J Lees, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 1, 1994
Motor response to levodopa in patients with parkinsonian motor fluctuations: a follow-up study over three years
A J Hughes, J P Frankel, P A Kempster, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 1, 1989
The effects of oral protein on the absorption of intraduodenal levodopa and motor performance
J P Frankel, P A Kempster, M Bovingdon, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 1, 1989
Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's disease
P A Kempster, J P Frankel, M Bovingdon, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 1, 1990
Diurnal differences in response to oral levodopa
J P Frankel, Z Pirtosek, P A Kempster, et al.
Lancet (London, England)
|
June 24, 1989
Treatment of Parkinson's disease with novel dopamine D2 agonist SK&F 101468
R Kapoon, Z Pirtosek, J P Frankel, et al.
Advances in Neurology
|
January 1, 1990
Effects of L-deprenyl on parkinsonian bradyphrenia
V M Eatough, P A Kempster, J P Frankel, et al.
Clinical Neuropharmacology
|
October 1, 1989
A double-blind, controlled study of high-dose L-deprenyl in the treatment of Parkinson's disease
J P Frankel, P A Kempster, C M Stibe, et al.
Lancet (London, England)
|
December 24, 1988
Role of subcutaneous apomorphine in parkinsonian voiding dysfunction
T J Christmas, P A Kempster, C R Chapple, et al.
Archives of Neurology
|
October 1, 1989
Anal sphincter dysfunction in Parkinson's disease
S E Mathers, P A Kempster, P J Law, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Lancet (London, England)
|
September 30, 1989
Use of apomorphine to test for dopamine responsiveness in Wilson's disease
J P Frankel, A Hughes, A J Lees, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 1, 1994
Motor response to levodopa in patients with parkinsonian motor fluctuations: a follow-up study over three years
A J Hughes, J P Frankel, P A Kempster, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 1, 1989
The effects of oral protein on the absorption of intraduodenal levodopa and motor performance
J P Frankel, P A Kempster, M Bovingdon, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 1, 1989
Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's disease
P A Kempster, J P Frankel, M Bovingdon, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 1, 1990
Diurnal differences in response to oral levodopa
J P Frankel, Z Pirtosek, P A Kempster, et al.
Lancet (London, England)
|
June 24, 1989
Treatment of Parkinson's disease with novel dopamine D2 agonist SK&F 101468
R Kapoon, Z Pirtosek, J P Frankel, et al.
Advances in Neurology
|
January 1, 1990
Effects of L-deprenyl on parkinsonian bradyphrenia
V M Eatough, P A Kempster, J P Frankel, et al.
Clinical Neuropharmacology
|
October 1, 1989
A double-blind, controlled study of high-dose L-deprenyl in the treatment of Parkinson's disease
J P Frankel, P A Kempster, C M Stibe, et al.
Lancet (London, England)
|
December 24, 1988
Role of subcutaneous apomorphine in parkinsonian voiding dysfunction
T J Christmas, P A Kempster, C R Chapple, et al.
Archives of Neurology
|
October 1, 1989
Anal sphincter dysfunction in Parkinson's disease
S E Mathers, P A Kempster, P J Law, et al.
Page
of 4